Alzheimer’s

Protein interactions unveil molecular insights into Down syndrome

FAM53C identified as a binding partner inhibiting DYRK1A kinase.

Statins’ potential to slow dementia sparks more research

Registry-based study on statins and cognitive decline in Alzheimer's.

New ALS treatments target unusual RNA structures

RNA condensates linked to ALS/FTD via C9orf72 expansion.

Higher dementia risk linked to irregular sleep patterns

Sleep regularity index linked to dementia and brain volume changes.

COVID-19 changes gene activity in olfactory mucosal cells in Alzheimer’s

Distinct immune responses after infection between AD patients and healthy individuals.

Early-onset dementia linked to newly identified protein

Frontotemporal lobar degeneration linked to TAF15 amyloid filaments.

Aging accelerates in transplant patients with older organs

Alzheimer's polygenic risk scores tied to different processes based on cell type.

Protein clumps can cause brain diseases

Prion protein cross-seeding deactivates TDP-43.

Neuroinflammation’s key role in Alzheimer’s revealed

The results have important implications for the design of microglia-centered therapeutics for AD.

Restoring youth to COVID-19 affected brains

Alleviating brain aging and COVID-19 pathology with senolytic therapy.

UC Irvine-led study discovers novel cause of brain hemorrhage

In vivo microhemorrhages linked to erythrocyte-brain endothelial interactions.

New study sheds light on how Alzheimer’s tau tangles begin

Inhibition of GCPII lowers pT217Tau in the brains of aged macaques.

Recent Stories